Insider Selling: CombiMatrix Director Sells $27,358 in Stock (CBMX)
CombiMatrix (NASDAQ:CBMX) Director R Judd Jessup unloaded 13,679 shares of the company’s stock on the open market in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $2.00, for a total transaction of $27,358.00. Following the completion of the transaction, the director now directly owns 31,174 shares in the company, valued at approximately $62,348. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Shares of CombiMatrix (NASDAQ:CBMX) opened at 2.05 on Monday. CombiMatrix has a 1-year low of $1.91 and a 1-year high of $4.44. The stock’s 50-day moving average is $2.20 and its 200-day moving average is $2.54. The company’s market cap is $22.7 million.
Separately, analysts at Zacks reiterated an “outperform” rating on shares of CombiMatrix in a research note on Friday, August 8th. They now have a $3.50 price target on the stock.
CombiMatrix Corporation is a molecular diagnostics company. The Company operates in the field of genetic analysis and molecular diagnostics through its wholly owned subsidiary, CombiMatrix Molecular Diagnostics, Inc located in Irvine, California.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.